Fig. 6 | Scientific Reports

Fig. 6

From: Inhibition of NLRP3 inflammasome contributes to paclitaxel efficacy in triple negative breast cancer treatment

Fig. 6

Differential expression in genes involved in breast carcinogenesis and NLRP3 inflammasome activation. MDA-MB-231 cells were transfected with NLRP3 siRNA for 72 h followed by incubation with 100 nM PTX for an additional 24 h. Statistical significance: “*” symbol was used for statistical comparisons between control and 100 nM PTX treatment; “#” symbol was used for statistical comparisons between 100 nM PTX treatment and NLRP3 siRNA transfection combined with 100 nM PTX; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, && p < 0.01, &&& p < 0.001 and &&&& p < 0.0001 (n = 3, biological replicates).

Back to article page